Genomic alterations in PDE genes or the biochemical inhibition of PDE function can sensitize NSCLC to PMX in vitro, independently of lung cancer histology (adenocarcinoma (AD) or squamous-cell carcinoma (SCC)). Here, ALDH7A1 is linked to Alzheimer disease.